TrianglePUBLICATIONS · 19171708
Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2009 Mar 10
- First author
- Escudier B
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2009 May 1; 27(13):2305
- note
- Source null
- related pmid
- Source null
- relationship
- Erratum in
- url
- Source null
Authors and identifiers
- name
- Escudier B
- type
- Author
- name
- Szczylik C
- type
- Author
- name
- Hutson TE
- type
- Author
- name
- Demkow T
- type
- Author
- name
- Staehler M
- type
- Author
- name
- Rolland F
- type
- Author
- name
- Negrier S
- type
- Author
- name
- Laferriere N
- type
- Author
- name
- Scheuring UJ
- type
- Author
- name
- Cella D
- type
- Author
- name
- Shah S
- type
- Author
- name
- Bukowski RM
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Escudier B
- type
- Author
- name
- Szczylik C
- type
- Author
- name
- Hutson TE
- type
- Author
- name
- Demkow T
- type
- Author
- name
- Staehler M
- type
- Author
- name
- Rolland F
- type
- Author
- name
- Negrier S
- type
- Author
- name
- Laferriere N
- type
- Author
- name
- Scheuring UJ
- type
- Author
- name
- Cella D
- type
- Author
- name
- Shah S
- type
- Author
- name
- Bukowski RM
- type
- Author
- bibliography ids
- nci-bib-cacdfb8a201c12d1d7fbf31a
- book metadata
- content sha256
- fc055d5ce9d7daaff37434969c2bfb05bc79531d75001887ac86427971e6f0d1
- document type
- citation
- dois
- 10.1200/JCO.2008.19.3342
- electronic publication date
- display
- 2009 Jan 26
- precision
- day
- year
- 2009
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19171708
- immutable id
- pubmed:19171708@fc055d5ce9d7daaff37434969c2bfb05bc79531d75001887ac86427971e6f0d1
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 8
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1280-9
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2009 May 1; 27(13):2305
- note
- Source null
- related pmid
- Source null
- relationship
- Erratum in
- url
- Source null
- outcomes validated
- false
- pmid
- 19171708
- provenance
- batch id
- 27a383f06e5fc3d04fad
- provider
- NCBI PubMed ESummary
- record sha256
- a5507f35466cd1db99e50a3f0c9a2990894b678385b5a16c3146d3665666fe5f
- response sha256
- 51f0f2a142dbd9b135e872b049b116f51941299445a5416feae10f12fac8d978
- retrieved at
- 2026-09-09T23:46:24.265787+00:00
- publication date
- display
- 2009 Mar 10
- precision
- day
- year
- 2009
- publication types
- Clinical Trial, Phase II
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma.
Preserved source evidence · Not medical advice